Heartflow (HTFL) Research & Development (2024 - 2026)
Heartflow (HTFL) posted quarterly Research & Development of $18.7 million for Q4 2025, up 52.01% year-over-year from $12.3 million in Q4 2024, and up 7.91% quarter-over-quarter from $17.3 million in Q3 2025.
Heartflow (HTFL) Research & Development (2024 - 2026) Analysis & Trends
Heartflow's Research & Development history runs 2 years deep, the most recent figure standing at $18.7 million for Q4 2025.
- In Q4 2025, Research & Development rose 52.01% year-over-year to $18.7 million; the TTM figure through Dec 2025 stood at $63.3 million (changed N/A YoY), while the FY2025 annual figure was $64.9 million, up 49.18% from the prior year.
- Research & Development for Q4 2025 stood at $18.7 million, up from $17.3 million in the prior quarter.
- The five-year high for Research & Development was $18.7 million in Q4 2025, with the low at $9.9 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | - |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 26.83 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 56.79 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 81.41 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 99.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 50.38 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 45.05 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 30.58 Mn |
| 10 | Privia Health | 2.78 Bn | 2.42 Bn | - | 8.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.58 Mn |
| Dec 31, 2025 | 18.67 Mn |
| Sep 30, 2025 | 17.30 Mn |
| Jun 30, 2025 | 15.03 Mn |
| Dec 31, 2024 | 12.28 Mn |
| Sep 30, 2024 | 11.86 Mn |
| Jun 30, 2024 | 9.93 Mn |